In this modern era of neuroscience, how can we take seriously the notion that an effective way to address the chronically relapsing brain disease of addiction is by recommending that those affected congregate frequently in rented church basements to discuss their addiction and recovery experiences?
Alcoholics Anonymous (AA) and its 12-step cousins are the oldest, best known, and most widely available recovery support groups. In recent decades, however, a number of alternatives have appeared that may be better suited for some people in recovery.
Alcoholics Anonymous (AA) occupies such a prominent place in popular culture and addiction treatment that it seems a little odd to question its effectiveness. But odd, counterintuitive questions about AA have been accumulating for years, and we finally have a book that collects them all in one place.
There’s been a big push in the past decade for screening, brief intervention, and referral to treatment (SBIRT), and evidence seems to support its effectiveness.
Informed consent—whether it be for psychotherapy, prescribing a medication, or performing a surgical procedure—is an ethical principle firmly established in law and medicine. While there has been no formal research on this subject, my experience suggests that many addiction treatment programs fail to obtain valid informed consent.
Naltrexone first hit the US market as an oral medication (ReVia) way back in 1984. Over the years, it developed a solid reputation for treating alcoholism and remains a first-line therapy today. Naltrexone was a bust, however, when it came to treating opioid addiction.
Get insight into the differences between methadone and buprenorphine when used to treat opioid addiction, in an interview with Gavin Bart, MD, PhD, FACP, FASAM, director of the division of addiction medicine at Hennepin County Medical Center in Minnesota.